Kim, H.S.; Kim, W.; Yun, W.-G.; Jung, H.-S.; Han, Y.; Lee, M.; Kwon, W.; Jang, J.-Y.; Park, J.S.
Novel Predictive Strategy Using CA19-9 and Fecal Elastase Levels to Make Treatment Decisions for Resectable Pancreatic Cancer: A Retrospective Study. Biomedicines 2025, 13, 62.
https://doi.org/10.3390/biomedicines13010062
AMA Style
Kim HS, Kim W, Yun W-G, Jung H-S, Han Y, Lee M, Kwon W, Jang J-Y, Park JS.
Novel Predictive Strategy Using CA19-9 and Fecal Elastase Levels to Make Treatment Decisions for Resectable Pancreatic Cancer: A Retrospective Study. Biomedicines. 2025; 13(1):62.
https://doi.org/10.3390/biomedicines13010062
Chicago/Turabian Style
Kim, Hyung Sun, Woojin Kim, Won-Gun Yun, Hye-Sol Jung, Youngmin Han, Mirang Lee, Wooil Kwon, Jin-Young Jang, and Joon Seong Park.
2025. "Novel Predictive Strategy Using CA19-9 and Fecal Elastase Levels to Make Treatment Decisions for Resectable Pancreatic Cancer: A Retrospective Study" Biomedicines 13, no. 1: 62.
https://doi.org/10.3390/biomedicines13010062
APA Style
Kim, H. S., Kim, W., Yun, W.-G., Jung, H.-S., Han, Y., Lee, M., Kwon, W., Jang, J.-Y., & Park, J. S.
(2025). Novel Predictive Strategy Using CA19-9 and Fecal Elastase Levels to Make Treatment Decisions for Resectable Pancreatic Cancer: A Retrospective Study. Biomedicines, 13(1), 62.
https://doi.org/10.3390/biomedicines13010062
